Position in TMO
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$2,645,676
-$1,001,968 QoQ
Shares Held
5,277
-28.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.00%
of 13F equity value
Holder Rank
#1,061
of 2,606 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Balefire, LLC holds $4,491,255 across 4 Diagnostics & Research names. TMO ranks #1 (58.9% of the industry book) .
All Filings in TMO
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,645,676 | 5,277 | Shares | Sole | 2026-07-07 | |
| 2026-03-31 | $3,647,644 | 7,421 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $4,450,755 | 7,681 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $4,052,342 | 8,355 | Shares | Sole | 2025-10-08 | |
| 2025-06-30 | $1,778,347 | 4,386 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $1,715,724 | 3,448 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $502,021 | 965 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $535,063 | 865 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $450,142 | 814 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $368,487 | 634 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $280,257 | 528 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $239,418 | 473 | Shares | Sole | 2023-12-06 | |
| 2023-06-30 | $246,787 | 473 | Shares | Sole | 2023-08-21 | |
| 2023-03-31 | $247,839 | 430 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $257,722 | 468 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $302,285 | 596 | Shares | Sole | 2022-11-17 | |
| 2022-06-30 | $302,606 | 557 | Shares | Sole | 2022-08-12 | |
| No filing history on record for this holder in this stock. | ||||||